its not a direct measure of body fat
For people with type 2 diabetes, the pancreas- the organ that makes insulin- is impaired, reducing the efficiency and speed of their metabolism
In general, tirzepatide tends to produce: Greater total weight loss over time, particularly in patients with metabolic dysfunction Stronger appetite suppression , including reduced cravings and food noise Faster metabolic response due to dual hormone pathway activation Because tirzepatide influences both appetite regulation and insulin sensitivity, it is often more effective for patients with insulin resistance, blood sugar instability, or stubborn weight that has not responded to diet, exercise, or GLP-1 therapy alone
Long-acting insulin combined with GLP-1 injections (once daily): Some people with type 2 diabetes use a single daily shot that includes a basal insulin and a GLP-1 medication, such as insulin glargine/lixisenatide (SOLIQUA 100/33) or insulin degludec/liraglutide (XULTOPHY 100/3.6)